[go: up one dir, main page]

HK1016410A - Stable liquid preparation of a vitamin complex for internal use - Google Patents

Stable liquid preparation of a vitamin complex for internal use Download PDF

Info

Publication number
HK1016410A
HK1016410A HK98117862.2A HK98117862A HK1016410A HK 1016410 A HK1016410 A HK 1016410A HK 98117862 A HK98117862 A HK 98117862A HK 1016410 A HK1016410 A HK 1016410A
Authority
HK
Hong Kong
Prior art keywords
vitamin
preparation
liquid preparation
internal use
complex
Prior art date
Application number
HK98117862.2A
Other languages
Chinese (zh)
Inventor
Murata Yutaka
Kikuchi Yuko
Ohsugi Tomohiko
Aoki Noriko
Murata Teiji
Kurazumi Toshiaki
Iwasa Akira
Original Assignee
Ss Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ss Pharmaceutical Co., Ltd. filed Critical Ss Pharmaceutical Co., Ltd.
Publication of HK1016410A publication Critical patent/HK1016410A/en

Links

Description

BACKGROUND OF THE INVENTION a) Field of the Invention
This invention relates to a stable liquid preparation of complex vitamin for internal use, and more specifically to a liquid preparation of complex vitamin for internal use, which remains stable even when stored for a long period at room temperature.
b) Description of the Related Art
Like vitamin B₆, vitamin B₁ and vitamin B₁₂ are closely associated with nervous functions and are effective for the improvement of neuroses such as neuralgia, arthralgia, peripheral neuritis and peripheral paralysis. A variety of tablets and capsules added with these vitamins are therefore available on the market.
As a dosage form, a liquid preparation generally features that compared with such tablets and capsules, the liquid preparation is more readily absorbed in the body and is easier to take. Nonetheless, no stable liquid preparation added with both vitamin B₁ and vitamin B₁₂ has been available on the market. This is attributed to the poor storage stability of a liquid preparation containing both of them.
As causes for the poor storage stability of the liquid preparation added with both vitamin B₁ and vitamin B₁₂, it is known that the stable pH ranges of these vitamins in an aqueous solution are different, i.e., pH 2-4 for vitamin B₁ and pH 4.5-5 for vitamin B₁₂ and also that SH-containing decomposition products of vitamin B₁ extremely lower the stability of vitamin B₁₂.
Further, sucrose is generally used as a sweetening agent in liquid preparations for internal use. Sucrose may however lower the stability of vitamin B₁ and vitamin B₁₂, depending on its concentration and the pH. Liquid preparations for internal use are also added with a corrigent, a flavoring agent, a buffer agent, a preservative and the like. These additives may also give adverse effects on the stability, thereby making it more difficult to formulate a liquid preparation for internal use, which contains vitamin B₁ and vitamin B₁₂.
SUMMARY OF THE INVENTION
An object of the present invention is therefore to provide a liquid preparation for internal use, which contains vitamin B₁ and vitamin B₁₂ and remains stable even when stored for a long period at room temperature.
With the foregoing circumstances in view, the present inventors have proceeded with extensive research. As a result, it has been found that the above-described problem can be overcome by the addition of vitamin B₁ and vitamin B₁₂ to a particular solution base, leading to the completion of the present invention.
In one aspect of the present invention, there is thus provided a stable liquid preparation of complex vitamin for internal use, said preparation containing vitamin B₁ and vitamin B₁₂, comprising a sugar alcohol as a sweetening agent, the pH of said preparation having been adjusted to 3.5 to 4.5.
In the liquid preparation of complex vitamin for internal use according to the present invention, the activities of vitamin B₁ and vitamin B₁₂ are stably maintained without reduction even when the liquid preparation is stored for a long period at room temperature.
DETAILED DESCRIPTION OF THE INVENTION AND PREFERRED EMBODIMENTS
In the present invention, examples of vitamin B₁ include thiamine and thiamine derivatives such as fursultiamine, octotiamine, thiamine disulfide, bisbentiamine, bisbutitiamine, bisibutiamine and benfotiamine as well as their salts. Their hydrochlorides, nitrates and the like can be mentioned as these salts. Vitamin B₁ can preferably be added in an amount of 1-50 mg per 50 mℓ of the liquid preparation of complex vitamin for internal use (hereinafter called "the present preparation").
On the other hand, cyanocobalamin is preferred as vitamin B₁₂. It is preferred to add it in an amount of 1-5,000 µg in the present preparation.
Illustrative sugar alcohols usable as sweetening agents in the present invention include xylitol, maltitol and sorbitol. Since these sugar alcohols have the merit that they are hardly digestible and do not raise the blood sugar level, they are advantageous particularly for those suffering from diabetes mellitus or obesity. The sugar alcohol can be added preferably in an amount of 0.5-20 g, notably 1-15 g in the present preparation.
The above sugar alcohol has lower sweetness compared with sucrose, so that sucrose can be added to the liquid preparation of complex vitamin for internal use according to the present invention to supplement the sweetness. From the standpoint of stability of both the vitamins, it is necessary to limit the amount of added sucrose below 5 g in the present preparation.
As a pH regulator for adjusting the pH to 3.5-4.5 in the present invention, it is preferred to use an organic acid such as citric acid, malic acid, tartaric acid or succinic acid or a salt thereof which can reduce the bitterness of added ingredients and can make the preparation easier to take, although hydrochloric acid, sodium hydroxide or the like may be used. Regarding the amount of such an organic acid or a salt thereof in the liquid preparation of complex vitamin for internal use, it is preferred to limit its amount below 0.5 g in the present preparation.
In addition to the above-described essential ingredients, the liquid preparation of complex vitamin for internal use according to the present invention can be added, as needed, with optional ingredients, for example, drug efficacy ingredients such as B₂ vitamins, B₆ vitamins, E vitamins, nicotinic acid, nicotinamide, pantothenic acids, pantothenol, aminoethylsulfonic acid, anhydrous caffeine, γ-oryzanol, and crude drug ingredients, e.g., ginseng; solubilizers such as ethanol and polyoxyethylene-hydrogenated castor oil; preservatives such as benzoic acid and alkyl parabens (i.e., alkyl parahydroxybenzoates); coloring agents such as caramel; and perfumes.
The present invention will hereinafter be described in further detail by the following Examples, Comparative Examples and Test. It should however be borne in mind that the present invention is not limited to them in any way whatsoever.
Example 1
The ingredients indicated in Table 1 were weighed in the amounts specified there and were then dissolved in purified water to give a total volume of 20 mℓ. The resulting solution was filtered through a 0.45-µm membrane filter and filled in a 20-mℓ amber-colored glass bottle. The glass bottle was plugged and then subjected to sterilization at 80°C for 20 minutes, whereby a liquid preparation of complex vitamin for internal use was produced.
Incidentally, thiamine nitrate and cyanocobalamin were added 115% on their indicated amounts. Table 1
Thiamine nitrate 10 mg
Cyanocobalamin 1,500 µg
Pyridoxine hydrochloride 100 mg
Nicotinamide 50 mg
Pantothenol 30 mg
D-Sorbitol solution (70%) 2,000 mg
Xylitol 2,500 mg
Malic acid 20 mg
Sodium hydroxide Sufficient to adjust the pH to 4.0
Sodium benzoate 14 mg
Butyl parahydroxybenzoate 1 mg
Caramel 100 mg
Perfume trace
Purified water Sufficient to produce 20 mℓ
Example 2
Following the procedures of Example 1, a liquid preparation of complex vitamin for internal use was produced in accordance with the formulation shown in Table 2. Table 2
Thiamine nitrate 10 mg
Cyanocobalamin 1,500 µg
Pyridoxine hydrochloride 50 mg
Nicotinamide 60 mg
Pantothenol 15 mg
D-Sorbitol solution (70%) 3,000 mg
Maltitol solution (75%) 4,000 mg
Citric acid 80 mg
Sodium citrate Sufficient to adjust the pH to 4.0 (15 mg)
Sodium benzoate 35 mg
Butyl parahydroxybenzoate 4 mg
Caramel 50 mg
Perfume trace
Purified water Sufficient to produce 50 mℓ
Example 3
Following the procedures of Example 1, a liquid preparation of complex vitamin for internal use was produced in accordance with the formulation shown in Table 3. Table 3
Fursultiamine hydrochloride 6 mg
Cyanocobalamin 1,500 µg
Pyridoxine hydrochloride 10 mg
Riboflavin sodium phosphate 5 mg
Nicotinamide 25 mg
Anhydrous caffeine 50 mg
Aminoethylsulfonic acid 1,000 mg
D-Sorbitol solution (70%) 7,000 mg
Purified sucrose 4,000 mg
Citric acid 200 mg
Sodium citrate Sufficient to adjust the pH to 3.7 (120 mg)
Sodium benzoate 35 mg
Butyl parahydroxybenzoate 4 mg
Caramel 5 mg
Perfume trace
Purified water Sufficient to produce 50 mℓ
Example 4
Following the procedures of Example 1, a liquid preparation of complex vitamin for internal use was produced in accordance with the formulation shown in Table 4. Table 4
Fursultiamine hydrochloride 6 mg
Cyanocobalamin 1,500 µg
Pyridoxine hydrochloride 10 mg
Nicotinamide 50 mg
Anhydrous caffeine 50 mg
Liquid ginseng extract 0.6 mℓ
Liquid polygonati rhizoma extract 0.4 mℓ
Liquid cistanchis herba extract 0.3 mℓ
D-Sorbitol solution (70%) 5,000 mg
Xylitol 1,500 mg
Purified sucrose 2,000 mg
Citric acid Sufficient to adjust the pH to 4.2 (100 mg)
Sodium citrate 120 mg
Polyoxyethylene-hydrogenated castor oil 60 10 mg
Sodium benzoate 35 mg
Butyl parahydroxybenzoate 4 mg
Caramel 5 mg
Perfume trace
Purified water Sufficient to produce 50 mℓ
Comparative Example 1
Following the procedures of Example 1, a liquid preparation of complex vitamin for internal use was produced in accordance with the formulation shown in Table 5. Table 5
Thiamine nitrate 10 mg
Cyanocobalamin 1,500 µg
Pyridoxine hydrochloride 50 mg
Nicotinamide 60 mg
Pantothenol 15 mg
Purified sucrose 2,000 mg
Isomerized sugar 6,500 mg
Citric acid 80 mg
Sodium citrate Sufficient to adjust the pH to 4.0
Sodium benzoate 35 mg
Butyl parahydroxybenzoate 4 mg
Caramel 50 mg
Perfume trace
Purified water Sufficient to produce 50 mℓ
Comparative Example 2
Following the procedures of Example 1, a liquid preparation of complex vitamin for internal use was produced in accordance with the formulation shown in Table 6. Table 6
Thiamine nitrate 10 mg
Cyanocobalamin 1,500 µg
Pyridoxine hydrochloride 50 mg
Nicotinamide 60 mg
Pantothenol 15 mg
Purified sucrose 7,500 mg
Citric acid 250 mg
Sodium citrate Sufficient to adjust the pH to 5.0
Sodium benzoate 35 mg
Butyl parahydroxybenzoate 4 mg
Caramel 50 mg
Perfume trace
Purified water Sufficient to produce 50 mℓ
Test
The liquid preparations of complex vitamin for internal use, which had been produced in Examples 1-4 and Comparative Examples 1-2, respectively, were stored at room temperature for 12 months and 24 months, followed by quantitative analyses of vitamin B₁ and vitamin B₁₂. The results of the stability test of vitamin B₁ are shown in Table 7, whereas the results of the stability test of vitamin B₁₂ are presented in Table 8.
The quantitative analyses were conducted by high performance liquid chromatography, and the stability of each liquid preparation is indicated by a value (%) on the indicated amount.
Measurement of Stability of Vitamin B
Table 7
After stored for 12 months After stored for 24 months
Example 1 107.7 100.7
Example 2 108.8 100.8
Example 3 110.9 104.1
Example 4 109.6 102.7
Comp.Ex. 1 104.5 95.2
Comp.Ex. 2 96.3 78.9
At the time of production: 115.0%
Measurement of Stability of Vitamin B₁₂
Table 8
After stored for 12 months After stored for 24 months
Example 1 104.2 93.7
Example 2 105.8 96.0
Example 3 107.0 99.0
Example 4 109.6 102.0
Comp.Ex. 1 99.5 83.0
Comp.Ex. 2 101.0 88.7
At the time of production: 115.0%
Results
As is evident from Table 7 and Table 8, vitamin B₁ and vitamin B₁₂ in each liquid preparation of complex vitamin for internal use according to this invention retained high stability.

Claims (7)

  1. A stable liquid preparation of complex vitamin for internal use, said preparation containing vitamin B₁ and vitamin B₁₂, comprising a sugar alcohol as a sweetening agent, the pH of said preparation having been adjusted to 3.5 to 4.5.
  2. The preparation according to claim 1, wherein citric, malic, tartaric or succinic acid or a salt thereof has been used as a pH regulator in an amount not greater than 0.5 g per preparation.
  3. The preparation according to claim 1, wherein said sugar alcohol is xylitol, maltitol or sorbitol.
  4. The preparation according to claim 3, wherein citric, malic, tartaric or succinic acid or a salt thereof has been used as a pH regulator in an amount not greater than 0.5 g per preparation.
  5. The preparation according to claim 1, wherein vitamin B₁ is thiamine or a derivative thereof or a salt of thiamine or the thiamine derivative; and vitamin B₁₂ is cyanocobalamin.
  6. The preparation according to claim 5, wherein citric, malic, tartaric or succinic acid or a salt thereof has been used as a pH regulator in an amount not greater than 0.5 g per preparation.
  7. The preparation according to claim 5, wherein said sugar alcohol is xylitol, maltitol or sorbitol.
HK98117862.2A 1993-10-14 1998-12-28 Stable liquid preparation of a vitamin complex for internal use HK1016410A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP256767/93 1993-10-14

Publications (1)

Publication Number Publication Date
HK1016410A true HK1016410A (en) 1999-10-29

Family

ID=

Similar Documents

Publication Publication Date Title
RU2274440C2 (en) Compositions stimulating hair growth
EP1335747B1 (en) A composition of sodium channel blocking compound
EP2649993B1 (en) Stabilizer of acetaminophen
EP2309983B1 (en) Pharmaceutical form comprising tetrahydrobiopterin
EP0648486B1 (en) Stable liquid preparation of a vitamin complex for internal use
EP1391202B1 (en) Liquid drug preparations
HK1016410A (en) Stable liquid preparation of a vitamin complex for internal use
JP2000007561A (en) Ambroxol hydrochloride aqueous solution preparation
EP3582765B1 (en) Midodrine hydrochloride oral solution and uses thereof
DE68912740T2 (en) Acyclic derivatives with diuretic properties.
JP2012025676A (en) Liquid medicine containing sumatriptan succinate for internal use
EP0906913A1 (en) Pteridinderivatives as NO synthase inhibitors
JPH11171793A (en) Vitamin B1 compound liquid
DE2841170A1 (en) Hypnotic drug contg. L-tryptophan - and cpds. blocking chemical bonding of latter on serum protein, and also L-tryptophan pyrrolase inhibitors
JPS6219535A (en) Lysozyme syrup agent
JP2001131070A (en) Liquid composition containing riboflavin
DE60219620T2 (en) L-ASCORBIC ACID 2-O-MALEIC ACID-A-TOCOPHEROLDIESTER-1-PROPANOL ADDUCT AND METHOD FOR THE PRODUCTION THEREOF
JP6633896B2 (en) Biotin-containing solution
JPS63313725A (en) Syrup agent
DE69904021T2 (en) LIQUID PHARMACEUTICAL PREPARATION CONTAINING ZOTEPIN
JP2002322062A (en) Liquid for internal use
DE2737735C3 (en) Medicines containing pirbutero and hydroxyzine
JP2000247883A (en) Liquid agent for internal use containing dihydropyridine- based compound
JP2003171283A (en) Xanthine oxidase inhibitor
DE3687448T2 (en) USE OF 6H-7,8-DIHYDROTHIAPYRANO (3,2D) PYRIMIDINES FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR USE AS HYPOGLYKAEMIC AGENTS OR AS A WEIGHTING AGENT FOR FAT-ADHESIVE PATIENTS.